Biosergen Completes First Cohort of BSG005 Clinical Trial, Shows Promising Potential in Drug-Resistant Fungal Infections
Reading Time: 4 minutes October 31, 2024 – Biosergen AB (“Biosergen”), a clinical-stage biotechnology company developing therapies for life-threatening fungal diseases, today announced the completion of treatment for the first cohort of patients in its proof-of-concept clinical trial for its antifungal drug-candidate BSG005. The cohort
Rule, Build, and Thrive in Tlatoani: Aztec Cities—Out Now in Steam Early Access
Reading Time: 2 minutes STOCKHOLM, October 31st, 2024 – Today, Paradox Arc, Perspective Games, and Bellwood Studios released their city-building game, Tlatoani: Aztec Cities, into Steam Early Access. The game features a deep simulation of an Aztec city-state along with beautiful hand-drawn 2D graphics that
Sinch Survey Reveals Major Gaps in Email Deliverability Despite 78% Recognizing its Importance
Reading Time: 3 minutes 53% of Senders Ignore Blocklist Monitoring, and 39% Neglect List Hygiene, Risking Deliverability and Customer Engagement ATLANTA, Georgia, USA and STOCKHOLM, Sweden– October 31, 20204 – Sinch (Sinch AB (publ) – XSTO: SINCH), which is pioneering the way the world communicates
Diagonal announces first pilot test at a stud with LAMPlify®
Reading Time: 2 minutes Read original Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) announces a partnership with Gocksta Stud (Gocksta Stuteri), led by Anne-Sophie Thiam, to conduct a three-month pilot study, which begins immediately. This pilot test will evaluate LAMPlify’s potential for rapid detection
Lundbeck announces positive results from phase III pivotal trial (SUNRISE) of Vyepti® (eptinezumab) in migraine prevention
Reading Time: 8 minutes Vyepti® confirms efficacy in new phase III pivotal SUNRISE trial, meeting primary endpoint with statistically significant reductions in mean monthly migraine days compared with placebo Vyepti® met all key secondary efficacy endpoints in the SUNRISE trial, and the treatment was generally
Vinpearl Woos Indian Luxury Travelers with Strategic Two-pronged Focus
Reading Time: 4 minutes Vietnam, with its rich cultural heritage and stunning natural beauty, has become an increasingly attractive destination for Indian travelers. Vinpearl’s focus on luxury wedding tourism and high-end MICE services has further enhanced the appeal of the country to this growing market.
Nomination Committee for Duni Group’s AGM 2025
Reading Time: < 1 minute Pursuant to a resolution adopted at Duni ABs (Duni Group’s) Annual General Meeting in 2024, a Nomination Committee has been appointed prior to the Annual General Meeting in 2025. Duni Group hereby announces the composition of the Nomination Committee. The
Picadeli reaches new heights with 250 salad bars across Finland
Reading Time: 3 minutes With the demand for healthy fast-food at an all-time high, Picadeli is celebrating a major milestone: over 250 salad bars now open in Finland. This achievement makes Picadeli the second largest fast-food chain in the country by number of outlets, surpassing
SAS recognized for customer-centric excellence with Five Star rating at 2025 APEX Awards
Reading Time: 3 minutes Travelers have once again placed Scandinavian Airlines (SAS) among the world’s best, awarding the airline a Five Star rating in the 2025 APEX global customer rankings. This recognition, based on nearly one million passenger reviews of 600 airlines worldwide, reflects SAS’
Exel Composites’ financial calendar and Annual General Meeting in 2025
Reading Time: 2 minutes EXEL COMPOSITES PLC STOCK EXCHANGE RELEASE 31 OCTOBER 2024 AT 9:15 EET Exel Composites will publish the following financial reports in 2025: Financial Statements Release 2024: 14 February 2025 at approximately 9:00 EET Business Review Q1 2025: 8 May 2025 at approximately 9:00 EET Half